Factor X (PRONATIV human prothrombin complex powder for injection vial and solution for injection vial)
What to know about Factor X — also sold as PRONATIV human prothrombin complex powder for injection vial and solution for injection vial: uses, side effects, interactions, and safety considerations for people taking it or caring for someone who is.
Factor X (brand names: PRONATIV human prothrombin complex powder for injection vial and solution for injection vial) is classified as Low risk (1 risk points) by AllMeds. It is a S4 medication under the TGA in Australia. Clotting factor replacement therapy carries minimal workplace impairment risk.
Key Takeaways
- TGA Schedule: S4 in Australia
- Risk level: Low (1 points)
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S4 | Not PBS listed |
Risk Profile
Clotting factor replacement therapy carries minimal workplace impairment risk.
How Factor X is regulated
Factor X is overseen by medicines regulators in each country. The rules below explain how it's scheduled, what oversight applies, and what to discuss with your doctor or pharmacist before starting, changing, or stopping this medication.
Australia TGA / PBS / State Schemes
Classified as S4 under the Therapeutic Goods Administration (TGA).
Check this medication against your full medication list
Run a full risk assessment including Factor X interactions and compliance checks.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Important: This page is general health information, not personal medical advice. If you have questions about your medication — including starting it, stopping it, changing the dose, or combining it with something else — speak with your doctor or pharmacist. For an emergency or suspected overdose, call your local emergency number or poison information service immediately. Information is drawn from regulator and clinical guideline sources (TGA, FDA, MHRA, NICE, PBS, CDC); see our methodology for details.